Overview
McDermott Will & Schulte is a proud sponsor of the American Conference Institute’s (ACI) 22nd Annual Paragraph IV Disputes conference. Partners Adam Burrowbridge and Art Dykhuis are speaking at the event, which convenes leaders from across the pharmaceutical patent industry to address the key issues shaping Hatch‑Waxman litigation and to frame emerging hot topics within the broader context of pre‑suit strategy, case filings, trial practice, and Federal Circuit appeals.
Adam Burrowbridge will speak on the panel “It’s Not Over Yet: Preparing Your Hatch‑Waxman Case for a Federal Circuit Appeal.” The session will provide practical guidance on positioning cases for Federal Circuit review, identifying issues most likely to attract the court’s attention, and developing effective arguments.
Art Dykhuis is speaking on the breakout session, “The Skinny on Carve‑outs and Carve‑ins: A Closer Look at Strategic Labeling Considerations and What Constitutes Induced Infringement.” His panel will offer insights into the evolving landscape for skinny and chubby labels, the role labeling and promotional materials play in induced infringement analyses, and the practical implications of recent case law and proposed legislative reforms.
Learn more about the conference here.